Breakthrough Sleep Drug May Have Fewer Side Effects

WSJ Live
6.4K
38 views
  • About
  • Export
  • Add to
Christopher Weaver joins Lunch Break with an update on the quest to better treat insomnia and Merck’s much-anticipated Suvorexant. Photo: Getty Images.


Copyright 2013, Dow Jones & Company, Inc.

0 comments